Cecilia Olivet, Timothé Feodoroff, Pia Eberhardt, Emma Lui, Stuart Trew
13 May 2013
As European Union (EU) member states consider the implications of environmentally risky shale gas development (fracking), negotiations are underway for a controversial EU-Canada Comprehensive Economic and Trade Agreement (CETA) which would grant investors the right to challenge governments’ decision to ban and regulate fracking.
Three United Nations Conventions provide the international legal framework on drug control, instructing countries to limit drug supply and use to medical and scientific purposes. Yet, debate continues on the decriminalisation, or even legalisation, of drugs, particularly cannabis. Models under development for the legal supply of cannabis are described in this analysis, as well as some of the questions they raise.
Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.
Reflections upon this year’s CND are mixed. On the one hand, some states went further than ever before in openly challenging the current regime on the grounds that, after a century, it needs modernising. That the government of Uruguay is currently considering a domestic policy on cannabis that would put it in breach of the Single Convention shows that, in one instance at least, we have moved beyond rhetoric and posturing.
Making banks and non-profits liable for the acts and social networks of their customers and beneficiaries while holding charities and CSOs responsible for the ‘extremist’ views and actions of their associates stifles freedom of association and expression and promotes self-censorship.
Published by Biowatch South Africa, this is a book about access to information, the right to know, and action in the public’s interest – a must-read for anyone campaigning for environmental or social justice.